TMR 조사 보고서 '세계의 인슐린 시장'은 2025-2035년 예측 기간 동안 시장 지표에 대한 가치 있는 인사이트를 얻기 위해 과거 및 현재의 성장 동향과 기회를 연구합니다. 본 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 설정하여 세계의 인슐린 시장 수익과 예측을 제공합니다. 또한 2025-2035년 세계의 인슐린 시장 연평균 성장률(CAGR%)도 제공합니다.
본 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 의견 형성자들과의 인터뷰를 수행하는 등 연구 노력의 대부분을 차지했습니다. 2차 연구는 주요 업체들의 제품 문헌, 연차 보고서, 보도 자료 및 관련 문서를 참조하여 인슐린 시장을 파악했습니다.
시장 현황
시장 매출(2024년)
203억 달러
시장 매출(2035년)
315억 달러
CAGR
4.1%
본 보고서는 세계의 인슐린 시장 경쟁 구도를 조사했습니다. 세계의 인슐린 시장에서 사업을 전개하는 주요 기업을 식별하고 각각을 다양한 속성으로 프로파일하고 있습니다. 기업 개요, 재무 현황, 최근 동향, SWOT 분석은 본 보고서에서 프로파일링된 세계 인슐린 시장 참여 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 인슐린 시장 분석과 예측(2020-2035년)
제5장 주요 인사이트
주요 산업 이벤트
주요국 및 지역별 역학
공급망 분석
기술적 진보
주요국 및 지역별 규제 시나리오
시장 개척 전략
최종 사용자 선호
주요 국가별 상환 시나리오
시장에서 최고 10개 기업
주요 제품 및 브랜드 분석
Porter's Five Forces 분석
PESTEL 분석
경쟁이 제공하는 제품의 벤치마크
제6장 세계 시장 분석과 예측 : 제품 유형별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 제품 유형별(2020-2035년)
속효형 인슐린
단시간 작용형 인슐린
중간 작용형 인슐린
지속형 인슐린
2상성 인슐린
시장의 매력 : 제품 유형별
제7장 세계 시장 분석과 예측 : 용도별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 용도별(2020-2035년)
1형 당뇨병
2형 당뇨병
임신성 당뇨
시장의 매력 : 용도별
제8장 세계 시장 분석과 예측 : 전달 디바이스별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 전달 디바이스별(2020-2035년)
펜
인슐린 펌프
주사기
제트
시장의 매력 : 전달 디바이스별
제9장 세계 시장 분석과 예측 : 공급원별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 공급원별(2020-2035년)
인간 인슐린
인슐린 아날로그
시장의 매력 : 공급원별
제10장 세계 시장 분석과 예측 : 유통 채널별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 유통 채널별(2020-2035년)
병원 약국
소매 약국
온라인 약국
시장의 매력 : 유통 채널별
제11장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제12장 북미 시장 분석과 예측
미국
캐나다
제13장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
스위스
네덜란드
기타 유럽
제14장 아시아태평양 시장 분석과 예측
중국
인도
일본
한국
호주 및 뉴질랜드
기타 아시아태평양
제15장 라틴아메리카 시장 분석과 예측
브라질
멕시코
아르헨티나
기타 라틴아메리카
제16장 중동 및 아프리카 시장 분석과 예측
GCC 국가
남아프리카
기타 중동 및 아프리카
제17장 경쟁 구도
시장 기업 : 경쟁 매트릭스(기업 등급별, 규모별)
시장 점유율 분석기업별(2024년)
기업 프로파일
Shanghai Fosun Pharmaceutical Co., Ltd.
Tonghua Dongbao
Eli Lilly and Company
Sanofi
Novo Nordisk A/S
Julphar
Biocon Ltd.
Becton, Dickinson, and Company
Ypsomed AG
Biodel, Inc.
B. Braun Melsungen AG
HBR
영문 목차
영문목차
Insulin Market- Scope of Report
TMR's report on the global Insulin Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Insulin Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Insulin Market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Insulin Market .
Market Snapshot
Market Value in 2024
US$ 20.3 Bn
Market Value in 2035
US$ 31.5 Bn
CAGR
4.1%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Insulin Market .
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Insulin Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Insulin Market .
The report delves into the competitive landscape of the global Insulin Market. Key players operating in the global Insulin Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Insulin Market profiled in this report.
Key Questions Answered in Global Insulin Market Report:
What are the opportunities in the global Insulin Market ?
What are the major drivers, restraints, opportunities, and threats in the Market ?
Which regional Market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the Market positions of different companies operating in the global Market ?
Insulin Market- Research Objectives and Research Approach
The comprehensive report on the global Insulin Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Insulin Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Insulin Market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Insulin Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Insulin Market Analysis and Forecasts, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Epidemiology by Key Countries/Regions
5.3. Supply Chain Analysis
5.4. Technological advancements
5.5. Regulatory Scenario by Key Countries/Regions
5.6. Go-to Market Strategy
5.7. End-user Preference
5.8. Reimbursement Scenario by Key Countries
5.9. Top 10 Players Operating In the Market Space- Global
5.10. Key Product/Brand Analysis
5.11. Porter's Five Forces Analysis
5.12. PESTLE Analysis
5.13. Benchmarking of Products offered by Competitors
6. Global Insulin Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020 to 2035
6.3.1. Rapid-acting insulin
6.3.2. Short-acting insulin
6.3.3. Intermediate-acting insulin
6.3.4. Long-acting insulin
6.3.5. Biphasic insulin
6.4. Market Attractiveness By Product Type
7. Global Insulin Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020 to 2035
7.3.1. Type 1 Diabetes
7.3.2. Type 2 Diabetes
7.3.3. Gestational Diabetes
7.4. Market Attractiveness By Application
8. Global Insulin Market Analysis and Forecasts, By Delivery Device
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Delivery Device, 2020 to 2035
8.3.1. Pens
8.3.2. Insulin Pumps
8.3.3. Syringes
8.3.4. Jets
8.4. Market Attractiveness By Delivery Device
9. Global Insulin Market Analysis and Forecasts, By Source
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Source, 2020 to 2035
9.3.1. Human Insulin
9.3.2. Insulin Analog
9.4. Market Attractiveness By Source
10. Global Insulin Market Analysis and Forecasts, By Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Distribution Channel, 2020 to 2035
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness By Distribution Channel
11. Global Insulin Market Analysis and Forecasts, By Region
11.1. Key Findings
11.2. Market Value Forecast By Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness By Region
12. North America Insulin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020 to 2035
12.2.1. Rapid-acting insulin
12.2.2. Short-acting insulin
12.2.3. Intermediate-acting insulin
12.2.4. Long-acting insulin
12.2.5. Biphasic insulin
12.3. Market Value Forecast By Application, 2020 to 2035
12.3.1. Type 1 Diabetes
12.3.2. Type 2 Diabetes
12.3.3. Gestational Diabetes
12.4. Market Value Forecast By Delivery Device, 2020 to 2035
12.4.1. Pens
12.4.2. Insulin Pumps
12.4.3. Syringes
12.4.4. Jets
12.5. Market Value Forecast By Source, 2020 to 2035
12.5.1. Human Insulin
12.5.2. Insulin Analog
12.6. Market Value Forecast By Distribution Channel, 2020 to 2035
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.7. Market Value Forecast By Country, 2020 to 2035
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Application
12.8.3. By Delivery Device
12.8.4. By Source
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Insulin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020 to 2035
13.2.1. Rapid-acting insulin
13.2.2. Short-acting insulin
13.2.3. Intermediate-acting insulin
13.2.4. Long-acting insulin
13.2.5. Biphasic insulin
13.3. Market Value Forecast By Application, 2020 to 2035
13.3.1. Type 1 Diabetes
13.3.2. Type 2 Diabetes
13.3.3. Gestational Diabetes
13.4. Market Value Forecast By Delivery Device, 2020 to 2035
13.4.1. Pens
13.4.2. Insulin Pumps
13.4.3. Syringes
13.4.4. Jets
13.5. Market Value Forecast By Source, 2020 to 2035
13.5.1. Human Insulin
13.5.2. Insulin Analog
13.6. Market Value Forecast By Distribution Channel, 2020 to 2035
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Switzerland
13.7.7. The Netherlands
13.7.8. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product Type
13.8.2. By Application
13.8.3. By Delivery Device
13.8.4. By Source
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Insulin Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020 to 2035
14.2.1. Rapid-acting insulin
14.2.2. Short-acting insulin
14.2.3. Intermediate-acting insulin
14.2.4. Long-acting insulin
14.2.5. Biphasic insulin
14.3. Market Value Forecast By Application, 2020 to 2035
14.3.1. Type 1 Diabetes
14.3.2. Type 2 Diabetes
14.3.3. Gestational Diabetes
14.4. Market Value Forecast By Delivery Device, 2020 to 2035
14.4.1. Pens
14.4.2. Insulin Pumps
14.4.3. Syringes
14.4.4. Jets
14.5. Market Value Forecast By Source, 2020 to 2035
14.5.1. Human Insulin
14.5.2. Insulin Analog
14.6. Market Value Forecast By Distribution Channel, 2020 to 2035
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
14.7.1. China
14.7.2. India
14.7.3. Japan
14.7.4. South Korea
14.7.5. Australia & New Zealand
14.7.6. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product Type
14.8.2. By Application
14.8.3. By Delivery Device
14.8.4. By Source
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Insulin Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2020 to 2035
15.2.1. Rapid-acting insulin
15.2.2. Short-acting insulin
15.2.3. Intermediate-acting insulin
15.2.4. Long-acting insulin
15.2.5. Biphasic insulin
15.3. Market Value Forecast By Application, 2020 to 2035
15.3.1. Type 1 Diabetes
15.3.2. Type 2 Diabetes
15.3.3. Gestational Diabetes
15.4. Market Value Forecast By Delivery Device, 2020 to 2035
15.4.1. Pens
15.4.2. Insulin Pumps
15.4.3. Syringes
15.4.4. Jets
15.5. Market Value Forecast By Source, 2020 to 2035
15.5.1. Human Insulin
15.5.2. Insulin Analog
15.6. Market Value Forecast By Distribution Channel, 2020 to 2035
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Argentina
15.7.4. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product Type
15.8.2. By Application
15.8.3. By Delivery Device
15.8.4. By Source
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Insulin Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Product Type, 2020 to 2035
16.2.1. Rapid-acting insulin
16.2.2. Short-acting insulin
16.2.3. Intermediate-acting insulin
16.2.4. Long-acting insulin
16.2.5. Biphasic insulin
16.3. Market Value Forecast By Application, 2020 to 2035
16.3.1. Type 1 Diabetes
16.3.2. Type 2 Diabetes
16.3.3. Gestational Diabetes
16.4. Market Value Forecast By Delivery Device, 2020 to 2035
16.4.1. Pens
16.4.2. Insulin Pumps
16.4.3. Syringes
16.4.4. Jets
16.5. Market Value Forecast By Source, 2020 to 2035
16.5.1. Human Insulin
16.5.2. Insulin Analog
16.6. Market Value Forecast By Distribution Channel, 2020 to 2035
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies
16.6.3. Online Pharmacies
16.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product Type
16.8.2. By Application
16.8.3. By Delivery Device
16.8.4. By Source
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
